BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

SpectraScience, Inc. (SCIE.PK) Reports Estimated Second Quarter Revenue of $310,000


7/9/2012 9:10:56 AM

SAN DIEGO, CA--(Marketwire - July 09, 2012) - SpectraScience, Inc. (PINKSHEETS: SCIE) (OTCQB: SCIE), a San Diego-based medical device company, today announced that it expects revenue of approximately $310,000 for the second quarter ended June 30, 2012. The Company also stated that it expects operating expenses in the quarter to be consistent with recent prior quarters.

"We began shipments of our WavSTAT4 Optical Biopsy System to PENTAX Europe just prior to the close of the quarter, which accounted for the revenue reported today," said Michael Oliver, SpectraScience's Chief Executive Officer. "We are preparing additional shipments under the initial purchase order, and beginning training programs and business development activities with PENTAX as part of the 5-year, 23-country distribution agreement signed last month."

Conference Call

As previously announced, the Company will hold a conference call today at 4:30 p.m. Eastern (1:30 p.m. Pacific) to provide an update on its business and conduct a question and answer session with investors.

Individuals interested in listening to the conference call may do so by dialing 877- 407-0782, or for international callers 201-689-8567. The call is also being webcast, and can be accessed at www.InvestorCalendar.com.

A telephone replay will be available through September 9, 2012 by dialing 877-660-6853, or for international callers 201-612-7415, and entering the Account #: 286, and the Conference ID #: 396984. The webcast will be available on the Company's Web site for 90 days following the completion of the call.

About SpectraScience, Inc.

SpectraScience is a San Diego based medical device company that designs, develops, manufactures and markets light-based analysis systems capable of determining whether tissue is normal, pre-cancerous or cancerous without physically removing tissue from the body. The WavSTAT Optical Biopsy System uses light to optically diagnose tissue and provide the physician with an immediate analysis. With approval for sale under the CE Mark for the European Union, the WavSTAT System is the first commercially available product that incorporates this innovative technology for clinical use.


Contact:
SpectraScience, Inc.
Jim Dorst
Chief Financial Officer
(858) 405-9933

Investor Relations
LHA
Don Markley
Email Contact
(310) 691-7100



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES